GlassScriptPhysician profile
Carrie E Mckenzie
NPI 1679047971
$2,148.18
in general payments reported to CMS, 2019-2025
20 companies · $416 in 2025
The $416 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $497 · 2022: $924 · 2023: $286 · 2024: $25.80 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $677 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $677.05 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $599.40 | 2021-2022 | |
| Silk Road Medical, INC. | $344.07 | 2021-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Boston Scientific Corporation | $292.11 | 2021-2025 | General - Angiography |
| W. L. Gore & Associates, INC. | $197.86 | 2021-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore-Tex Vascular Graft |
| Stryker Corporation | $163.86 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
| E.R. Squibb & Sons, L.L.C. | $103.71 | 2021 | |
| Medtronic, INC. | $75.26 | 2021-2022 | |
| Terumo Medical Corporation | $69.66 | 2022-2024 | Azur Cx Detachable |
| Janssen Pharmaceuticals, INC | $47.37 | 2021-2023 | Xarelto |
| Shockwave Medical, INC | $39.11 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $38.48 | 2021 | |
| Cardiva Medical, INC. | $25.84 | 2022 | |
| Kerecis Limited | $24.92 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Actelion Pharmaceuticals US, INC. | $22.18 | 2025 | Opsumit, Uptravi |
| Merck Sharp & Dohme LLC | $22.02 | 2025 | Verquvo |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $21.87 | 2023 | Restoreflow, Artegraft Vascular Graft |
| Davol INC. | $17.92 | 2021 | |
| Exact Sciences Corporation | $17.00 | 2023 | Cologuard Collection Kit |
| Bioventus LLC | $13.37 | 2022 | |
| Reprise Biomedical, INC. | $12.17 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Mckenzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.